- Wells JT, Perrillo R. Hepatitis B. In Feldman M, Friedman LS, Brandt LJ, ed. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Philadelphia: Saunders-Elsevier, 2016: 1309–1331.
- Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA. The increasing burden of imported chronic hepatitis B—United States, 1974–2008. PLoS One 2011;6 (12): e27717.
- Sharma S, Carballo M, Feld JJ, Janssen HL. Immigration and viral hepatitis. J Hepatol 2015;63 (2): 515–522.
- Colvin HM, Mitchell AE. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington DC: National Academies Press, 2010.
- Ward JW, Byrd KK. Hepatitis B in the United States: a major health disparity affecting many foreign-born populations. Hepatology 2012;56 (2): 419–421.
- Hasan SS, Ma J, Kang F, Song J, Fang-Hollingsworth Y, Sears D. Hepatitis prevention project in the Korean American community in Killeen, Texas. Proc (Bayl Univ Med Cent) 2015;28 (4): 435–437.
- Ramirez J, Duddempudi AT, Sana MM, Hasan SS, de los Santos M, Song J, Fang-Hollingsworth Y, Gupta SS, Sears DM. Screening for hepatitis B in patients with lymphoma. Proc (Bayl Univ Med Cent) 2015;28 (4): 438–442.
- Hwang JP, Barbo AG, Perrillo RP. Hepatitis B reactivation during cancer chemotherapy: an international survey of the membership of the American Association for the Study of Liver Diseases. J Viral Hepat 2015;22 (3): 346–352.
- Perrillo RP, Gish R, Falck-Ytter YT. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy. Gastroenterology 2015;148 (1): 221–244.e3.
- Hwang JP, Fisch MJ, Zhang H, Kallen MA, Routbort MJ, Lal LS, Vierling JM, Suarez-Almazor ME. Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract 2012;8 (4): e32–e39.
- Sun WC, Hsu PI, Yu HC, Lin KH, Tsay FW, Wang HM, Tsai TJ, Chen WC, Lai KH, Cheng JS. The compliance of doctors with viral hepatitis B screening and antiviral prophylaxis in cancer patients receiving cytotoxic chemotherapy using a hospital-based screening reminder system. PLoS One 2015;10 (2): e0116978.
- Sampedro B, Hernández-López C, Ferrandiz JR, Illaro A, Fábrega E, Cuadrado A, Iruzubieta P, Menéndez S, Cabezas J, Crespo J. Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB project. Hepatology 2014;60 (1): 106–113.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 28, 2015 - Issue 4